Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Oncology Institute (TOI) Depreciation & Amortization (IS) (2021 - 2025)

Oncology Institute (TOI) has disclosed Depreciation & Amortization (IS) for 5 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (IS) rose 9.54% year-over-year to $1.7 million, compared with a TTM value of $7.0 million through Sep 2025, up 14.0%, and an annual FY2024 reading of $6.3 million, up 7.05% over the prior year.
  • Depreciation & Amortization (IS) was $1.7 million for Q3 2025 at Oncology Institute, down from $1.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $1.8 million in Q2 2025 and bottomed at $777000.0 in Q1 2021.
  • Average Depreciation & Amortization (IS) over 5 years is $1.3 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (IS) skyrocketed 49.74% in 2023, then decreased 7.36% in 2024.
  • Year by year, Depreciation & Amortization (IS) stood at $920000.0 in 2021, then grew by 29.57% to $1.2 million in 2022, then soared by 32.3% to $1.6 million in 2023, then rose by 8.24% to $1.7 million in 2024, then increased by 0.94% to $1.7 million in 2025.
  • Business Quant data shows Depreciation & Amortization (IS) for TOI at $1.7 million in Q3 2025, $1.8 million in Q2 2025, and $1.8 million in Q1 2025.